Search Within

Maura N Dickler

Formats
  1. Meeting Abstract (141)
  2. Journal Article (115)
  3. Book Section (5)
  4. Conference Paper (1)
  5. Review (1)
Groups
  1. Department of Medicine (169)
  2. Solid Tumor Oncology Division (163)
  3. Breast Medicine Service (155)
  4. Survivorship Research (152)
  5. Epidemiology and Biostatistics (105)
  6. Population Sciences Research Program (89)

More Groups

People
  1. Clifford Hudis (102)
  2. Larry Norton (64)
  3. Shari Goldfarb (51)
  4. Chau Dang (39)
  5. Sujata Patil (35)
  6. Tiffany Traina (34)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (6)
  4. 2019 (4)
  5. 2018 (20)
  6. 2017 (29)

More Years

Publications
  1. Journal of Clinical Oncology (69)
  2. Cancer Research (41)
  3. Breast Cancer Research and Treatment (18)
  4. Clinical Cancer Research (14)
  5. Annals of Oncology (10)
  6. Journal of Sexual Medicine (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. American Association for Cancer Research (57)
  3. Springer (26)
  4. Elsevier Inc. (18)
  5. Oxford University Press (18)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (263)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumor cell and endothelial cell data from a phase 11 evaluation of lapatinib and bevacizumab in HER2-overexpressing metastatic breast cancer
    Meeting Abstract

    Rugo, H. S.; Dickler, M.; Franco, S.; Stopeck, A.; Lyandres, J.; Melisko, M.; Lahiri, S.; Arbushites, M.; Koehler, M.; Lin, Y.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Adjuvant dose-dense doxorubicin-cyclophosphamide x 4 with or without bevacizumab is safe: No evidence of short-term changes in left ventricular ejection fraction
    Meeting Abstract

    Morris, P. G.; Dickler, M.; Mcarthur, H.; Traina, T.; Godfrey, L.; Steingart, R.; Rugo, H.; Lin, N.; Moy, B.; Come, S.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H.; Rugo, H.; Nulsen, B.; Traina, T.; Patil, S.; Zhou, Q.; Steingart, R.; Dang, C.; Park, J.; Moasser, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Bone scintigraphy (BS) may no longer be relevant in the era of integrated PET/CT for women undergoing evaluation for suspected metastatic breast cancer (MBC)
    Meeting Abstract

    Mcarthur, H. L.; Lynch, C.; Morris, P.; Larson, S.; Grabski, K.; Howard, J.; Patil, S.; Hudis, C. A.; Dickler, M. N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Haplotype analysis of bevacizumab-induced hypertension
    Meeting Abstract

    Frey, M. K.; Olvera, N.; Bogomolniy, F.; Dao, F.; Borsu, L.; Konner, J.; Barakat, R. R.; Dickler, M.; Levine, D. A.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • A randomized phase 2 trial of low dose (6 mg daily) versus high dose (30 mg daily) estradiol for patients with estrogen receptor positive aromatase inhibitor resistant advanced breast cancer
    Meeting Abstract

    Ellis, M. J.; Dehdahti, F.; Kommareddy, A.; Jamalabadi-Majidi, S.; Crowder, R.; Jeffe, D. B.; Gao, F.; Fleming, G.; Silverman, P.; Dickler, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Final results from a phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Dickler, M.; Franco, S.; Stopeck, A.; Ma, W.; Nulsen, B.; Lyandres, J.; Melisko, M.; Lahiri, S.; Arbushites, M.; Koehler, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Long-term health outcomes of a decision aid: Data from a randomized trial of Adjuvant! in women with localized breast cancer
    Journal Article

    Vickers, A. J.; Elkin, E. B.; Peele, P. B.; Dickler, M.; Siminoff, L. A.
    Medical Decision Making (2009)

    Fulltext@MSK | Save
  • Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: A phase 2 randomized study
    Journal Article

    Ellis, M. J.; Gao, F.; Dehdashti, F.; Jeffe, D. B.; Marcom, P. K.; Carey, L. A.; Dickler, M. N.; Silverman, P.; Fleming, G. F.; Kommareddy, A.; more...
    JAMA - Journal of the American Medical Association (2009)

    Fulltext@MSK | Save